Dudediligence.

Enovis Corporation

ENOVNYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$558.8MMar ’25$564.5MJun ’25$548.9MSep ’25$548.9MOct ’25$575.8MDec ’25$589.2MMar ’26$589.2MApr ’26$582.8MJul ’26
Net income, by quarter
−$56.0MMar ’25−$36.7MJun ’25−$571.1MSep ’25−$571.1MOct ’25−$520.6MDec ’25−$8.8MMar ’26−$8.8MApr ’26−$1.2MJul ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.43B$1.56B$1.71B$2.11B$2.25B
Gross profit$777.7M$869.4M$990.8M$1.18B$1.35B
Operating income−$62.8M−$71.2M−$65.7M−$775.7M−$1.12B
Net income$71.7M−$13.3M−$33.3M−$825.5M−$1.18B
Operating cash flow$356.1M−$55.9M$135.0M$113.5M$217.3M
Free cash flow$251.9M−$161.3M$12.8M−$67.2M$19.9M
Cash$680.3M$24.3M$36.2M$48.2M$36.4M
Debt$2.09B$259.3M$466.2M$1.33B$1.30B
Shares outstanding52.1M54.2M54.6M55.9M57.2M